Cold & Cough Remedies (Pharmacies) - BRICS

  • BRICS
  • Revenue in the Cold & Cough Remedies market is projected to reach US$11.24bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.24%, resulting in a market volume of US$15.94bn by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$3.41 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in BRICS is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this growth.

Customer preferences:
Customers in the BRICS countries have a high demand for cold and cough remedies from pharmacies. This is primarily due to the prevalence of respiratory infections and the need for quick relief from symptoms such as coughing, congestion, and sore throat. Customers also prefer over-the-counter remedies that are easily accessible and affordable. Additionally, there is a growing preference for natural and herbal remedies, as customers are becoming more health-conscious and seeking products with fewer side effects.

Trends in the market:
One of the key trends in the Cold & Cough Remedies (Pharmacies) market in BRICS is the increasing popularity of combination products. These products offer multiple benefits in a single formulation, such as relieving cough, congestion, and pain simultaneously. Combination products are convenient for customers and provide a comprehensive solution to their cold and cough symptoms. Another trend is the rise of online pharmacies, which offer a wide range of cold and cough remedies for customers to choose from. Online platforms provide greater convenience and accessibility, especially in countries with large rural populations.

Local special circumstances:
In Brazil, the Cold & Cough Remedies (Pharmacies) market is influenced by the country's tropical climate, which contributes to a higher incidence of respiratory infections. In Russia, the market is driven by the long and harsh winters, which make people more susceptible to colds and coughs. In India, the market is influenced by the country's high population density and pollution levels, which increase the risk of respiratory infections. In China, the market is shaped by the country's rapid urbanization and industrialization, leading to higher pollution levels and respiratory health issues.

Underlying macroeconomic factors:
The Cold & Cough Remedies (Pharmacies) market in BRICS is also influenced by underlying macroeconomic factors. Economic growth and rising disposable incomes in these countries have led to increased healthcare spending, including the purchase of cold and cough remedies. Additionally, urbanization and changing lifestyles have resulted in higher stress levels and decreased immunity, leading to a higher demand for remedies to combat cold and cough symptoms. Government initiatives to improve healthcare infrastructure and increase access to healthcare services have also contributed to the growth of the market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in BRICS is growing due to customer preferences for accessible and affordable remedies, trends such as the popularity of combination products and online pharmacies, local special circumstances such as climate and pollution levels, and underlying macroeconomic factors such as economic growth and government initiatives. This market is expected to continue its growth trajectory in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)